🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It isn’t always obvious from the outside, but monopolistic health systems mean lower wages, lower quality, and a lower standard of living for every American. I am proud to work with Joe Lonsdale, Abe Sutton and others at Cicero Institute to help make healthcare cheaper.

This chain is worth reading. One of the clearest breakdowns I have read of how the #WH policy apparatus actually works.

The #healthpolicy lessons I learned from #COVID19

Really glad to see Luciana Borio, MD on this list. She is truly qualified.

Worth a read. It is too easy to overlook aspects of the human suffering #COVID has inflicted. This piece brings isolation to life.

Hopeful #IPI can represent a point of continuity between the #Trump and #Biden administrations.

I support the #MostFavoredNation drug pricing policy as it balances curbing high drug prices with encouraging innovation. It is because I support the policy that I am disappointed HHS issued it via a legally vulnerable IFR, instead of an NPRM. blog.petrieflom.law.harvard.edu/2020/11/24/mos…

New from Abe Sutton: Issuing the Most Favored Nation Interim Final Rule Was a Mistake blog.petrieflom.law.harvard.edu/2020/11/24/mos…

Smart idea by CMSGov to incorporate current #1332Guidance in the 2022 #NBPP. Somewhat skeptical #NBPP will be finalized before the end of the term, but state flexibility is an idea worth enshrining in regulation.

And the reason we did the Health Care Choice and Competition report was so Republicans could have a roadmap for health reform built on improving the broken incentives that are everywhere in our health sector. hhs.gov/sites/default/…

Jim Lytle and my breakdown the #OPO final rule, the most recent regulatory change made as part of #AdvancingAmericanKidneyHealth. We walk through the content of the rule and potential next steps to build on the progress made

As the Senate turns to considering Xavier Becerra's nomination, my list of slightly too technical questions #HELP & #Finance Senators should consider asking

This is ill advised. Nothing in the text of the EO suggests the Biden team has thought the impact of taking away insurance options. Reversing the #ICHRA regulations initiated by EO 13813 would likely harm the #IndividualMarket and doesn't seem to have a point.

An unfortunate result of today's EO is that the President ended the requirement for a biannual report on federal & state policies that raise health care prices & lower quality by restricting choice and competition. So, this might be the only such report: hhs.gov/sites/default/…

Roses are red, Violets are blue. Direct Contracting deserves 5 years, So it can get a full review! #CMS #CMMI #healthpolicyvalentines

Over 40,000 people die of end‐stage kidney disease each year. Many of those deaths could be prevented. Ike Brannon, Josh Morrison of WaitList Zero, American Enterprise Institute’s Sally Satel & Alan Viard, Abe Sutton, and Mario Macis share ideas to increase organ donation… cato.org/regulation/sum…

WOW this story. I've written about issues with UNOS/organ transplants in the past, but this report is explosive.

Today, the CMS Innovation Center launched our new strategy to protect federal taxpayers and Make America Healthy Again through: 1) evidence-based prevention 2) patient empowerment 3) choice and competition Read more: go.cms.gov/46ToHDX. MAHA